Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Immunotherapy and gene therapy.

Elizabeth Simpson¹

¹Imperial College, MRC Clinical Sciences Centre, Hammersmith Hospital, London, W12 ONN, UK. elizabeth.simpson@csc.mrc.ac.uk

Idrugs : the Investigational Drugs Journal

|April 2, 2004

Summary

This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

The Effects of Medicaid Payment and Payment-to-Cost Ratio on Nursing Home Five-Star Quality Ratings.

Journal of the American Medical Directors Association·2025

Same author

Does Medicaid Cover the Cost of Nursing Home Care? Variation By Ownership Status, Payer-Mix, and Staffing Level.

Medical care·2025

Same author

Knowledge-based immune-therapeutic advances for transplantation and cancer.

Immunotherapy advances·2025

Same author

Community science as a potential tool to monitor animal demography and human-animal interactions.

Scientific reports·2025

Same author

Health and Liver Diagnostic Markers Influencing Glycemia in Subjects with Prediabetes: Preview Study.

Diagnostics (Basel, Switzerland)·2025

Same author

Continuing Implications of the COVID-19 Pandemic for Older Adults.

Journal of aging & social policy·2024

Same journal

Filibuvir, a non-nucleoside NS5B polymerase inhibitor for the potential oral treatment of chronic HCV infection.

IDrugs : the investigational drugs journal·2010

Same journal

Remimazolam, a short-acting GABA(A) receptor agonist for intravenous sedation and/or anesthesia in day-case surgical and non-surgical procedures.

IDrugs : the investigational drugs journal·2010

Same journal

LX-1031, a tryptophan 5-hydroxylase inhibitor that reduces 5-HT levels for the potential treatment of irritable bowel syndrome.

IDrugs : the investigational drugs journal·2010

Same journal

Dexpramipexole, the R(+) enantiomer of pramipexole, for the potential treatment of amyotrophic lateral sclerosis.

IDrugs : the investigational drugs journal·2010

Same journal

Lu-AA21004, a multimodal serotonergic agent, for the potential treatment of depression and anxiety.

IDrugs : the investigational drugs journal·2010

Same journal

Florbetapir (18F), a PET imaging agent that binds to amyloid plaques for the potential detection of Alzheimer's disease.

IDrugs : the investigational drugs journal·2010

See all related articles

This review covers advances in immunotherapy and gene therapy for cancer, genetic disorders, and infections. Key developments include novel vaccines, suicide gene therapy, and T-cell therapies, showing promise for patient treatment.

Area of Science:

Immunotherapy and Gene Therapy
Oncology
Infectious Diseases
Immunology

Background:

Review of state-of-the-art and translational prospects for therapeutic interventions.
Focus on killing tumor cells, correcting genetic defects, and developing vaccines for chronic infections.
Exploration of basic science concepts including dendritic cells, T-cell receptors, and immune response manipulation.

Framework:

Anticancer DNA vaccines incorporating helper and cancer target epitopes (e.g., immunoglobulin idiotypes, melanoma-associated antigens, minor histocompatibility antigens).
Vaccines designed to reduce viral load in HIV/AIDS patients using similar principles.
Suicide gene therapy utilizing the bacterial nitroreductase gene (ntr) and prodrug CB-1954 for tumor cell targeting.

Related Experiment Videos

Implementation:

Gene therapy for severe combined immunodeficiency (SCID) by introducing common gamma-chain genes into hematopoietic stem cells via retroviral transduction.
Successful immune reconstitution in SCID patients, with a noted complication of lymphoproliferative disease in some cases due to insertional mutagenesis.
Adoptive transfer of T-cells targeting specific antigens (minor histocompatibility antigens, CMV, Epstein-Barr virus antigens) for leukemia, CMV infection, and nasopharyngeal carcinoma.

Implications:

Advances in vaccine design, delivery, and immunomodulation for autoimmune diseases.
Potential for improved cancer treatments through DNA vaccines and suicide gene therapy.
New strategies for managing chronic infections and genetic disorders, highlighting the potential and challenges of gene and cell-based therapies.